The Indian government is committed to increasing spending on its infrastructure, including that related to overall health care, and is also determined to keep a check on the prices of medicines, the nation's President, Pratibha Devisingh Patil, has told Parliament. The total will rise to 9% of Gross Domestic Product, with some 140.0 billion rupees ($2.99 billion) going to investment to revive some public sector companies, she said.
Speaking to a joint session of parliamentarians earlier this month, President Patil noted that drugs and pharmaceuticals play an important role in India's health care.
Manufacturing undertakings
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
| Headless Content Management with Blaze